4

OWNERSHIP DOCUMENT

Company: Armata Pharmaceuticals, Inc.
Filed: April 15, 2022
Period of Report: April 13, 2022
Accession Number: 0001104659-22-046459

View Document ↗ View on SEC.gov ↗